Mette Strange

The glutamate receptor GluR5 agonist (S)-2-amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid and the 8-methyl analogue: synthesis, molecular pharmacology, and biostructural characterization.

Peter Naur, Hans Bräuner-Osborne, P. Naur, 2009, Journal of medicinal chemistry.

Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial

W. Sheu, N. Tandon, M. Farkouh, 2018, Diabetes, obesity & metabolism.

Functional characterisation of homomeric ionotropic glutamate receptors GluR1-GluR6 in a fluorescence-based high throughput screening assay.

A. A. Jensen, H. Bräuner‐Osborne, Mette Strange, 2006, Combinatorial chemistry & high throughput screening.